UDK: 616.379-008.64-085.31

EFFECT OF ANTIBODIES TO C-FINAL FRAGMENT OF -SUBUNIT INSULIN RECEPTOR ON THE QUALITY OF LIFE INDICATORS IN PATIENTS WITH TYPE 2 DIABETES

N. V. Rogova, I. V. Kulicova, V. I. Stacenko, V. O. Ostrovskaya

Кафедра клинической фармакологии ВолгГМУ

Abstract

Inclusion of extremely low doses of antibodies to the C-final fragment of -subunit insulin receptor in complex therapy of type 2 diabetes can significantly improve the quality of life in this group of patients. The improvement of the quality of life occurs as a result of improvement of social adaptation and of patients’ satisfaction with medical aid, and of reduction in manifestation of cardiovascular diseases and gastro-intestinal disorders.

Keywords

type 2 diabetes, extremely low doses of antibodies to the C-final fragment of -subunit insulin receptor, complex hypoglycemic therapy, quality of life questionnaire.

Contacts

Куликова Инна Викторовна — аспирант кафедры клинической фармакологии и интенсивной терапии ВолгГМУ, e-mail: inkins2007@rambler.ru